BDNF and Alzheimer disease: ApoE4 subjects were found to have significantly lower serum BDNF levels [132], and a BDNF reduction contributes to lower cognitive performance in both AD apathetic patients and female ApoE4 carriers [157] and non-demented subjects [158].